Dermata Therapeutics, Inc. (DRMA) stock
DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.57−0.03 (-4.75%)
Close on Nov 17, 2026Market cap $2.29MP/E –Yield –
Dermata Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Dermata Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 360.1×, with a median of 1.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.3 |
| 2025 | Dec 31, 2025 | 0.5× | +0.0 |
| 2024 | Dec 31, 2024 | 0.5× | −4.1 |
| 2023 | Dec 29, 2023 | 4.6× | −154.5 |
| 2022 | Dec 30, 2022 | 159.0× | −119.4 |
| 2021 | Dec 31, 2021 | 278.4× | – |
See a number that looks wrong?